Skip to main content
Equillium, Inc. (EQ)
NASDAQ: EQ · IEX Real-Time Price · USD
0.870
-0.040 (-4.40%)
At close: Jul 19, 2024, 4:00 PM
0.880
+0.010 (1.13%)
Pre-market: Jul 22, 2024, 8:11 AM EDT

Equillium Revenue

Equillium had revenue of $37.89M in the twelve months ending March 31, 2024, with 53.80% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.69M with 20.39% year-over-year growth. In the year 2023, Equillium had annual revenue of $36.08M with 128.97% growth.

Revenue (ttm)
$37.89M
Revenue Growth
+53.80%
P/S Ratio
0.81
Revenue / Employee
$861,227
Employees
44
Market Cap
30.67M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.08M20.33M128.97%
Dec 31, 202215.76M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cutera 196.64M
CareCloud 113.02M
Spectral AI 19.30M
Evogene 9.19M
Longeveron 978.00K
VYNE Therapeutics 423.00K
Revenue Rankings

EQ News

More News